Immuneering CorpIMRX
IMRX on Nasdaq: pharmaceutical preparations.
Immuneering Corp, ticker IMRX, is a healthcare company listed on Nasdaq operating in pharmaceutical preparations.
Detailed business segments for Immuneering Corp aren't currently in our reference dataset.
IMRX on the desk: alerts, trims, and member tracking.
Below is the outcome history for IMRX from Stock Sensei's alert feed. Entry, target, and stop levels, plus the chart-level reasoning, are members-only.
- BUYJan 7, 2025Hit+68.86%
- BUYDec 12, 2024Hit+10.40%
- BUYOct 15, 2024Hit+4.74%
- BUYOct 15, 2024Hit+12.29%
Full details unlock inside the app
Common questions about this stock.
What is IMRX?
IMRX is the trading symbol for Immuneering Corp, listed on Nasdaq in the healthcare sector.
What sector is IMRX in?
Immuneering Corp (IMRX) is classified in the healthcare sector, specifically pharmaceutical preparations, based on its SEC SIC classification.
Has Stock Sensei traded IMRX?
Yes, IMRX has appeared in the Stock Sensei alert feed 4 times, including 4 calls that hit target. The "Stock Sensei's calls on IMRX" section above lists the recent history; entry, target, and stop levels are members-only.
Where does IMRX trade?
IMRX trades on Nasdaq.
Is IMRX a stock or an ETF?
IMRX is a publicly-traded common stock, not an ETF.
Trade IMRX alongside Stock Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.